Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-19

Clinical Trial Update: Home-based Training and Supplementation in DM1 Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating home-based training and supplementation in patients with Myotonic Dystrophy Type 1 is ongoing (status unknown).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: McMaster University | Conditions: Myotonic Dystrophy 1 | Phase 3 | Status: UNKNOWN